Particle.news

Download on the App Store

Skin Swabs Validated for Seven-Year-Preclinical Parkinson’s Detection

Validated through TD-GC-MS mass spectrometry with scent trials delivered by hyperosmic volunteers matched with trained canines, the sebum swab test now advances to multicenter clinical evaluation.

Image
image: PeopleImages iStock
Joy Milne smelt husband Les's Parkinson's disease 12 years before he was diagnosed (Photo: Joy Milne)
Image

Overview

  • A University of Manchester-led study published in npj Parkinson’s Disease demonstrates that sebum skin swabs can identify Parkinson’s biomarkers up to seven years before motor symptoms emerge.
  • Using Thermal Desorption-Gas Chromatography-Mass Spectrometry, researchers pinpointed 55 volatile compounds that distinguish healthy volunteers, isolated REM Sleep Behavior Disorder individuals and Parkinson’s patients.
  • Hyperosmic volunteer Joy Milne correctly identified sebum samples from iRBD participants who were later clinically diagnosed with Parkinson’s.
  • In a double-blind trial reported in the Journal of Parkinson’s Disease, trained dogs achieved up to 80% sensitivity and 98% specificity in detecting Parkinson’s from skin swabs.
  • Building on three-year longitudinal sampling by Dr Drupad Trivedi, the research is moving into multicenter validation to enable practical clinical deployment of the non-invasive test.